Enzalutamide FDA approval date

The FDA approved Enzalutamide (Xtandi) on 31 Aug 2012.

FDA approval date
31 Aug 2012

Drug identity checked against registry records

Also recorded as Xtandi

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2012-08-31DayEnzalutamideFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA203415", "applicant_as_listed_by_fda": "ASTELLAS", "brand_names": ["XTANDI"], "active_ingredients": ["ENZALUTAMIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20120831", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026